166 related articles for article (PubMed ID: 7295568)
21. Clinical, biochemical and morphological responses of patients with villous atrophy to oral betamethasone valerate and clobetasone butyrate.
Bramble MG; Watson AJ; Scott J; Peters TJ; Record CO
Digestion; 1981; 22(6):281-8. PubMed ID: 7037504
[TBL] [Abstract][Full Text] [Related]
22. Effect of hydrocortisone-17-butyrate, hydrocortisone, and clobetasol-17-propionate on prolyl hydroxylase activity in human skin.
Oikarinen A; Hannuksela M
Arch Dermatol Res; 1980; 267(1):79-82. PubMed ID: 6247982
[No Abstract] [Full Text] [Related]
23. Induction of drug metabolising enzymes in the skin by topical steroids.
Finnen MJ; Herdman ML; Shuster S
J Steroid Biochem; 1984 May; 20(5):1169-73. PubMed ID: 6610079
[TBL] [Abstract][Full Text] [Related]
24. Topical application of potent glucocorticoids augments epidermal beta-adrenergic adenylate cyclase response in vivo.
Kajita S; Iizuka H; Hirokawa M; Tsutsui M; Mizumoto T
Acta Derm Venereol; 1986; 66(6):491-6. PubMed ID: 2433868
[TBL] [Abstract][Full Text] [Related]
25. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
26. Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05%. A controlled clinical comparison in the treatment of atopic dermatitis in children.
Lassus A
Int J Dermatol; 1984 Oct; 23(8):565-6. PubMed ID: 6389385
[TBL] [Abstract][Full Text] [Related]
27. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
Glade CP; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
[TBL] [Abstract][Full Text] [Related]
28. Unexpected clobetasol propionate profile in human stratum corneum after topical application in vitro.
Mueller B; Anissimov YG; Roberts MS
Pharm Res; 2003 Nov; 20(11):1835-7. PubMed ID: 14661929
[TBL] [Abstract][Full Text] [Related]
29. [Dermal and systemic side effects of fluocortin butylester. Comparative skin tearing experiments with active principles from commercial preparations].
Kapp JF; Gliwitzki B; Josefiuk P; Weishaupt W
Arzneimittelforschung; 1977; 27(11a):2206-13. PubMed ID: 580030
[TBL] [Abstract][Full Text] [Related]
30. Comparative anti-inflammatory efficacy of topical corticosteroids with low glaucoma-inducing potential.
Leibowitz HM; Ryan WJ; Kupferman A
Arch Ophthalmol; 1992 Jan; 110(1):118-20. PubMed ID: 1731703
[TBL] [Abstract][Full Text] [Related]
31. [Systemic effects of topically applied clobetasone 17-butyrate ointment--comparative studies with hydrocortisone 17-butyrate ointment (author's transl)].
Nihon Hifuka Gakkai Zasshi; 1980; 90(6):491-502. PubMed ID: 6967986
[No Abstract] [Full Text] [Related]
32. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
[TBL] [Abstract][Full Text] [Related]
33. [Studies on toxicity of clobetasone-17-butyrate (II)--chronic toxicity in rats (author's transl)].
Tamura J; Sato N; Moriwaki T; Tatami A; Ezaki H; Nagasawa R; Aoishi M; Okamura C; Sutoh M; Bando T; Matsumoto M; Hashimoto K
J Toxicol Sci; 1980 May; 5(2):177-201. PubMed ID: 7452742
[TBL] [Abstract][Full Text] [Related]
34. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
Winter GD; Wilson L
Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
[TBL] [Abstract][Full Text] [Related]
35. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT.
Guichard A; Humbert P; Tissot M; Muret P; Courderot-Masuyer C; Viennet C
Int J Pharm; 2015 Feb; 479(2):422-9. PubMed ID: 25556056
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of anthralin inflammation. 2. Effect of pretreatment with glucocorticoids, anthralin and removal of stratum corneum.
Lawrence CM; Shuster S
Br J Dermatol; 1985 Jul; 113(1):117-22. PubMed ID: 4015968
[TBL] [Abstract][Full Text] [Related]
37. Double-blind clinical trial of topical steroids in anterior uveitis.
Dunne JA; Travers JP
Br J Ophthalmol; 1979 Nov; 63(11):762-7. PubMed ID: 389282
[TBL] [Abstract][Full Text] [Related]
38. Objective assessment of topical corticosteroids and non-steroidal anti-inflammatory drugs in methyl-nicotinate-induced skin inflammation.
Duteil L; Queille C; Poncet M; Ortonne JP; Czernielewski J
Clin Exp Dermatol; 1990 May; 15(3):195-9. PubMed ID: 2364573
[TBL] [Abstract][Full Text] [Related]
39. Treatment of bullous pemphigoid with topical clobetasol propionate.
Westerhof W
J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
[TBL] [Abstract][Full Text] [Related]
40. Hypothalamic-pituitary-adrenal function in children with atopic dermatitis treated with clobetasone butyrate and its clinical evaluation.
Boner AL; Richelli C; De Stefano G; Valletta EA; Ferrari S; Mengoni M
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):118-20. PubMed ID: 2985514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
